Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rusanen, H.
Right arrow Articles by Hassinen, I. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rusanen, H.
Right arrow Articles by Hassinen, I. E.

Neurology, Vol 45, Issue 6 1188-1192, Copyright © 1995 by American Academy of Neurology


ARTICLES

Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA

H Rusanen, K Majamaa, U Tolonen, AM Remes, R Myllyla and IE Hassinen
Department of Neurology, University of Oulu, Finland.

A novel feature of demyelinating polyneuropathy was observed in a patient with the tRNA(Leu(UUR)) mutation at base pair 3243 of the mitochondrial DNA. Based on electrodiagnostic examination, the polyneuropathy was defined as being of the demyelinating, mixed (motor more than sensory) type. In a 1-year follow-up we observed approximately 7% reduction in both the motor and sensory conduction velocities. The other clinical features of the proband included a mild to moderate cognitive impairment and a combined hearing loss with a moderate sensorineural component. The proportion of the mutant genome found in the muscle of the proband was 29%, but the mutation was not found in his blood. A wide variability of the clinical phenotype was observed in the family of the proband. Heteroplasmic mutation was detected in the blood of most family members. The proportion of abnormal mitochondrial DNA was highest in the proband's brother, who had clinically definite mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, while the mutant genome was less frequent or absent in the subjects with less severe phenotypes and in healthy individuals. The findings on this pedigree emphasize the need for studies of complete families in the search for new clinical phenotypes of mutations in mitochondrial DNA.


This article has been cited by other articles:


Home page
Arch NeurolHome page
P. Kaufmann, J. M. Pascual, Y. Anziska, C. L. Gooch, K. Engelstad, S. Jhung, S. DiMauro, and D. C. De Vivo
Nerve Conduction Abnormalities in Patients With MELAS and the A3243G Mutation.
Arch Neurol, May 1, 2006; 63(5): 746 - 748.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. S. Clay, M. Behnia, and K. K. Brown
Mitochondrial Disease : A Pulmonary and Critical-Care Medicine Perspective
Chest, August 1, 2001; 120(2): 634 - 648.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.